AmerisourceBergen Corp (ABC):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AmerisourceBergen Corp (ABC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7153
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AmerisourceBergen Corp (AmerisourceBergen) is a pharmaceutical sourcing and distribution services company. It offers a wide range of services ranging from drug distribution to manufacturer solutions including niche premium logistics services, reimbursement and pharmaceutical consulting services, pharmacy automation, inventory management, and pharmacy management. The company distributes a complete range of branded and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, equipment and related services. It offers its products and services to pharmaceutical and biotech manufacturers, and healthcare providers including mail order pharmacies, acute care hospitals, independent pharmacies and others. In addition, the company provides pharmacy services to certain specialty drug patients. AmerisourceBergen is headquartered in Chesterbrook, Pennsylvania, the US.

AmerisourceBergen Corp (ABC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
AmerisourceBergen Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
AmerisourceBergen Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
AmerisourceBergen Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
AmerisourceBergen Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
AmerisourceBergen Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
AmerisourceBergen Corp, Medical Equipment, Deal Details 11
Private Equity 11
Frazier Healthcare Led Consortium Completes Acquisition Of AndersonBrecon From AmerisourceBergen For US$308 Million 11
Debt Offering 13
AmerisourceBergen Raises USD500 Million in Public Offering of 4.3% Senior Notes Due 2047 13
AmerisourceBergen Raises USD750 Million in Public Offering of 3.45% Senior Notes Due 2027 15
Acquisition 17
Walgreens Boots Alliance May Acquire Remaining 74% Stake in AmerisourceBergen 17
AmerisourceBergen Acquires PharMEDium Healthcare from Clayton, Dubilier & Rice for USD2.58 Billion 18
Intelligent Hospital Systems Acquires AmerisourceBergen Technology 20
AmerisourceBergen Corp – Key Competitors 21
AmerisourceBergen Corp – Key Employees 22
AmerisourceBergen Corp – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 26
Strategy And Business Planning 26
Aug 29, 2018: ICS opens new third-party logistics pharmaceutical distribution center 26
Jun 19, 2017: AmerisourceBergen Structures Operating Model and Executive Leadership Team to Offer a More Cohesive and Unified Customer Experience, Enhance Growth and Drive Long-Term Value 27
Financial Announcements 28
Aug 02, 2018: AmerisourceBergen posts fiscal 2018 Q3 results 28
May 02, 2018: AmerisourceBergen Reports Fiscal 2018 Second Quarter Results 29
Feb 06, 2018: AmerisourceBergen Reports Fiscal 2018 First Quarter Results 32
Nov 02, 2017: AmerisourceBergen Reports Fiscal 2017 Fourth Quarter and Year End Results 35
Aug 03, 2017: AmerisourceBergen Reports Third Quarter Fiscal Year 2017 Results 40
May 04, 2017: AmerisourceBergen Reports Second Quarter Fiscal Year 2017 Results 43
Jan 31, 2017: AmerisourceBergen Reports First Quarter Fiscal Year 2017 Results 46
Corporate Communications 49
Sep 10, 2018: AmerisourceBergen Announces Financial Leadership Change 49
Sep 19, 2017: AmerisourceBergen and the AmerisourceBergen Foundation Commit More Than $100,000 to Support Victims of Hurricanes Harvey and Irma 50
Legal and Regulatory 51
Jul 10, 2017: AmerisourceBergen Recognized as “Best In Class” for Specialty Distribution Quality 51
Jun 23, 2017: CPPA Accredits US Bioservices, a part of AmerisourceBergen, for Specialty Pharmacy 52
Government and Public Interest 53
Nov 13, 2017: AmerisourceBergen Urges Policymakers to Support Regulator and Industry Data Transparency to More Effectively Combat Opioid Abuse 53
Product News 54
Feb 13, 2017: IntrinsiQ Specialty Solutions and ION Solutions Provide Independent Oncology, Urology Practices Improved Access to Clinical Trials with the Launch of AdvanceIQ Network 54
Other Significant Developments 55
May 17, 2018: Centers for Medicare and Medicaid Services Approves IntrinsiQ Specialty Solutions as a Qualified Clinical Data Registry 55
Aug 29, 2017: PrescribeWellness Partners With AmerisourceBergen to Support Enhanced Services for Pharmacies in the Elevate Provider Network 56
Jul 19, 2017: NCCN Guidelines and NCCN Templates to be Integrated into ION Solutions’ IntelliDoseTxM Treatment Management Module 57
Jul 14, 2017: Good Neighbor Pharmacy Launches Estimator Tool to Assist Pharmacists In Managing The Impact of DIR Fees 58
May 01, 2017: AmerisourceBergen Announces New Five-Year Pharmaceutical Supply Agreement with Express Scripts 59
Jan 24, 2017: ION Solutions to Provide Patient Engagement Technology to its Nationwide Oncology Network with HealthGrid 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
AmerisourceBergen Corp, Medical Equipment, Key Facts, 2017 2
AmerisourceBergen Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AmerisourceBergen Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
AmerisourceBergen Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
AmerisourceBergen Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
AmerisourceBergen Corp, Deals By Market, 2012 to YTD 2018 9
AmerisourceBergen Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Frazier Healthcare Led Consortium Completes Acquisition Of AndersonBrecon From AmerisourceBergen For US$308 Million 11
AmerisourceBergen Raises USD500 Million in Public Offering of 4.3% Senior Notes Due 2047 13
AmerisourceBergen Raises USD750 Million in Public Offering of 3.45% Senior Notes Due 2027 15
Walgreens Boots Alliance May Acquire Remaining 74% Stake in AmerisourceBergen 17
AmerisourceBergen Acquires PharMEDium Healthcare from Clayton, Dubilier & Rice for USD2.58 Billion 18
Intelligent Hospital Systems Acquires AmerisourceBergen Technology 20
AmerisourceBergen Corp, Key Competitors 21
AmerisourceBergen Corp, Key Employees 22
AmerisourceBergen Corp, Subsidiaries 24

List of Figures
AmerisourceBergen Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AmerisourceBergen Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AmerisourceBergen Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AmerisourceBergen Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AmerisourceBergen Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
AmerisourceBergen Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
AmerisourceBergen Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
AmerisourceBergen Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[AmerisourceBergen Corp (ABC):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HeartWare International Inc-医療機器分野:企業M&A・提携分析
    Summary HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that co …
  • Lam Research Corporation:企業の戦略・SWOT・財務分析
    Lam Research Corporation - Strategy, SWOT and Corporate Finance Report Summary Lam Research Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Targovax ASA (TRVX):製薬・医療:M&Aディール及び事業提携情報
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG0, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline …
  • Elmet Technologies, Inc.:企業の戦略・SWOT・財務情報
    Elmet Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Elmet Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ibersol S.G.P.S., S.A.:企業の戦略・SWOT・財務分析
    Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report Summary Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Federal Electricity & Water Authority:電力:M&Aディール及び事業提携情報
    Summary Federal Electricity & Water Authority (FEWA) owned by the Ministry of Electricity and Water, is an energy utility that produces electricity and distillates sea water. It generates electricity from natural gas; and distillates water in multiple effect distillation (MED) and reverse osmosis (R …
  • FMR LLC:企業の戦略的SWOT分析
    FMR LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Sonova Holding AG:企業の戦略・SWOT・財務分析
    Sonova Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sonova Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CardioDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary CardioDx Inc (CardioDx) is a cardiovascular genomic diagnostics company. It undertakes the development of clinically validated tests in the areas of coronary artery disease, cardiac arrhythmias and heart failure. The company’s flagship product, Corus CAD gene expression test is used for asse …
  • Guided Therapeutics Inc (GTHP):医療機器:M&Aディール及び事業提携情報
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-inv …
  • Insulet Corp (PODD)-製薬・医療分野:企業M&A・提携分析
    Summary Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes OmniPod insulin management system, an insulin infusion system for diabetic patients. OmniPod insulin management system consists of OmniPod, a disposable insulin infusion device and the Personal Dia …
  • H. Lee Moffitt Cancer Center & Research Institute Inc-製薬・医療分野:企業M&A・提携分析
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services suc …
  • Edinburgh Molecular Imaging Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM I …
  • Tadano Ltd:企業の戦略・SWOT・財務分析
    Tadano Ltd - Strategy, SWOT and Corporate Finance Report Summary Tadano Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析
    Summary SuppreMol GmbH (SuppreMol), a subsidiary of Baxalta Inc, is a biopharmaceutical company that develops therapeutics in the areas of autoimmune, chronic inflammatory diseases, and allergies. The company’s lead drug candidate is extensively profiled in in-vitro, ex-vivo and in-vivo experiments. …
  • Kyowa Hakko Kirin Co., Ltd.:企業のM&A・事業提携・投資動向
    Kyowa Hakko Kirin Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kyowa Hakko Kirin Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Massmart Holdings Limited (MSM):企業の財務・戦略的SWOT分析
    Massmart Holdings Limited (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Cabot Oil & Gas Corporation (COG)-石油・ガス分野:企業M&A・提携分析
    Summary Cabot Oil & Gas Corporation (Cabot) is an independent oil and gas company, which develops, and explores for oil and gas properties primarily in the continental US. It focuses on developing natural gas resources in the Marcellus shale in northeast Pennsylvania and oil development in the Eagle …
  • Altavia SA:企業の戦略的SWOT分析
    Altavia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Apollo Global Management Inc:企業の戦略・SWOT・財務分析
    Apollo Global Management Inc - Strategy, SWOT and Corporate Finance Report Summary Apollo Global Management Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆